Articles Posted in Best Business And Class Action Lawyers Near Chicago

Under the new federal “Speak Out Act,” employers will no longer be able to enforce pre-dispute non-disclosure and non-disparagement clauses to disputes involving sexual assault and sexual harassment claims. The new law, which passed with bipartisan support in Congress, was signed into law by President Biden on December 7. The new law took effect immediately.

The goal of the new law is to prevent the practice of using pre-dispute agreements to silence employees from reporting sexual impropriety in the workplace. Employers’ use of non-disparagement agreements (NDAs) to keep employees’ sexual harassment claims quiet came under scrutiny during the #MeToo movement.

The exact impact of the new law is not clear yet, however. A key limitation to the law is its application only to pre-dispute agreements. This means that NDAs containing non-disclosure or non-disparagement clauses entered into after a dispute concerning sexual assault or harassment has arisen are not prohibited or covered by the new law. However, employers still cannot preclude employees from reporting violations of employment laws to agencies entrusted with enforcing such laws, like the Equal Employment Opportunity Commission.  Additionally, the law does not define the term “dispute,” making it unclear whether a dispute requires the filing of a lawsuit or whether a complaint to a manager or HR qualifies as a dispute. Continue reading ›

The U.S. Food and Drug Administration recently published a proposed rule that, if implemented, would update the labeling standards that food products must meet in order to be labeled as “healthy.” The FDA first established a definition for “healthy” in 1994, and at that time nutrition science and federal dietary guidance focused more on the individual nutrients contained in food. According to the FDA, the proposed rule would “align the definition of ‘healthy’ with current nutrition science, the updated Nutrition Facts label and the current Dietary Guidelines for Americans,” with the goal of assisting consumers to increase their consumption of under-consumed dietary components.

The proposed rule would achieve this goal by requiring “healthy” foods to contain a minimum quantity of at least one of the specified food groups or subgroups recommended by the Dietary Guidelines such as fruits and vegetables, while limiting over-consumed ingredients that may lead to negative health consequences such as sodium or added sugars. The FDA’s proposed framework for the updated definition of “healthy” focuses on ensuring that foods labeled as healthy can qualify to bear the title by helping consumers to build a diet consistent with current dietary recommendations. Continue reading ›

Sex trafficking requires more than one person to be involved in the process. So it should come as no surprise that the allegations against Jeffrey Epstein for sex trafficking didn’t stop with Epstein. His wife, Ghislaine Maxwell, was also found guilty of child sex trafficking and other crimes in connection with the abuse she and her husband committed on an ongoing basis.

Epstein and Maxwell were both very well-connected people, so it’s no wonder that people have speculated as to who knew about the sex trafficking before Epstein was arrested and the public became aware of his crimes. The horror and scope of the crimes has also led many to believe that it could not have been as secretive as many of those connected to Epstein have claimed. Since Epstein’s arrest, everyone from celebrities to politicians on both sides of the aisle have been accused of at least knowing about – if not directly participating in – Epstein’s sex trafficking. Continue reading ›

Executors and trustees have a large amount of responsibility with respect to the assets they manage and to the beneficiaries for whose benefit they manage such assets. However, with a high degree of responsibility comes a high degree of accountability. That accountability comes in the form of the fiduciary duties that trustees and executors owe to the beneficiaries of an estate or trust. Chief among those fiduciary duties are the duties of loyalty, care, impartiality, and disclosure.

One way that executors and trustees can breach their fiduciary duties is by engaging in fraud. Executor or trustee fraud occurs when the executor or trustee uses deceit to misappropriate estate or trust assets for themselves or someone else not entitled to receive them. Claims of executor or trustee fraud can have serious consequences, including holding the executor or trustee personally liable for the losses suffered by the beneficiaries.

Examples of ways that an executor or trustee can commit fraud against the beneficiaries include:

  • Misappropriating assets of the estate or trust
  • Withholding distributions from beneficiaries
  • Distributing less than what a beneficiary is entitled
  • Hiding or omitting estate or trust assets
  • Failing to notify beneficiaries
  • Falsifying liabilities
  • Charging inflated fees
  • Selling assets for below market value to someone connected to the trustee or executor such as a friend or family member.

Continue reading ›

In a case that has potentially far-reaching implications for fee petitions, the Illinois Third District appellate court formally adopted a framework for considering such petitions laid out by the Supreme Court nearly four decades ago. Perhaps just as important, the Third District rebuffed the trial court’s reduction of attorney fees awarded to a successful plaintiff without explaining the reasoning for the reduction. The Court ultimately reversed the trial court’s award and remanded the case for further consideration of the plaintiff’s fee petition.

The plaintiff in the case, Austin Casey III, bought a used vehicle from the defendant, Rides Unlimited Chicago, Inc. The vehicle broke down two hours into Casey’s return trip to his home in Michigan. Casey had the vehicle towed back to Rides Unlimited the same day and requested a refund of the purchase price. Rides Unlimited refused. Casey then sued Rides Unlimited alleging violations of the various statutes including the Consumer Fraud and Deceptive Business Practices Act (Consumer Fraud Act). After discovery, Casey filed a motion for summary judgment on his claim that Rides Unlimited violated Section 2L of the Consumer Fraud Act.

Section 2L prohibits a vehicle dealership from “exclud[ing], modify[ing], or disclaim[ing] the implied warranty of merchantability . . . before midnight of the 15th calendar day after delivery of a used motor vehicle or until a used motor vehicle is driven 500 miles after delivery, whichever is earlier.” It further provides that any “attempt to exclude, modify, or disclaim the implied warranty of merchantability or to limit the remedies for a breach of the warranty in violation of this Section renders a purchase agreement voidable at the option of the purchaser.”

The trial court granted Casey’s motion for summary judgment, awarded Casey the purchase price, and dismissed Casey’s other claims. Casey then filed a petition for attorney fees under Section 10a(c) of the Consumer Fraud Act, which provides that a court “may award, in addition to the relief provided in this Section, reasonable attorney’s fees and costs to the prevailing party.” Casey sought $10,640 in attorney fees and $454.52 in costs, for a total of $11,094.52. The trial court held a hearing on the fee petition and ultimately granted the petition but reduced the fee award to only $2,500. Casey appealed the trial court’s reduced fee award.

The Third District court of appeals granted leave to the National Association of Consumer Advocates and the Illinois Trial Lawyers Association to file an amicus curiae brief in support of Casey’s position that the trial court erred in reducing the attorney fee award. Our own Patrick Austermuehle authored the amicus brief that ultimately resulted in the Third District’s reversal and remand of the case back to the trial court to reconsider Casey’s petition for attorney fees. Continue reading ›

After passing one of the strictest non-compete laws in the nation, the District of Columbia Council has responded to criticisms about the bill by passing the Non-Compete Clarification Amendment Act of 2022 which significantly scales back key aspects of the non-compete ban law enacted back in 2021 but which has not yet gone into effect after the Council has delayed its enactment several times in response to feedback from employer groups.

The non-compete ban, passed by the Council in 2020 and enacted in 2021, sought to impose a near-universal ban on simultaneous and post-termination employment restrictions for employees working in D.C. Since the inception of the ban, it has been subject to much criticism and numerous extensions of its effective date. However, the Clarification Amendment, which will take effect on October 1, 2022, changes the scope of the ban from nearly all non-compete agreements to only those whose total annual compensation is less than $150,000 ($250,000 for medical specialists). Compensation is defined to include more than just salary but accounts for bonuses, commissions, overtime premiums, and vested stock as well but does not include “fringe benefits other than those paid to the employee in cash or cash equivalents.”

The Clarification Amendment will now proceed to the desk of the Mayor, where it is expected to be signed, and then will be subject to a 30-day congressional review period which likely will expire in mid-to-late November. The amendment contains a number of significant “clarifications” to the non-compete ban law and gives D.C. employers options for utilizing non-compete agreements and other policies, such as conflict of interest policies, that were set to be prohibited. Continue reading ›

Approximately 38,000 consumer lawsuits have been filed against Johnson & Johnson for allegedly including asbestos in their baby powder, which allegedly caused ovarian cancer and mesothelioma. Executives at Johnson & Johnson allegedly knew about the risks of asbestos for decades and still included it in their baby powder. Those same executives deny the allegations that their product is contaminated or that it caused anyone to get sick.

The company finally pulled its baby powder off the shelves in 2020, but only because bad publicity had hurt sales, according to the giant pharmaceutical company.

The results of the lawsuits against Johnson & Johnson have been a mixed bag. The company has emerged victorious in some of those lawsuits but has been ordered to pay billions of dollars to plaintiffs in other lawsuits.

People with ovarian cancer or mesothelioma are too sick to work and need caregivers to tend to their basic needs, which means either a family member can’t work, or they need to hire a full-time caregiver. Those expenses could be covered by a settlement in the lawsuit against Johnson & Johnson, but the company, which is valued at $400 billion, has found a legal loophole to avoid facing those lawsuits. Continue reading ›

In a recent decision, the U.S. Court of Appeals for the Eleventh Circuit revived a class action lawsuit filed against Avior Airlines accusing the airline of forcing passengers to pay undisclosed fees in order to board flights from Miami to Venezuela. In its decision, the appeals court ruled that the class action suit could proceed and that the district court erred when it found the claims preempted by the Airline Deregulation Act.

Plaintiffs Roberto Hung Cavalieri and Sergio Enrique Isea purchased tickets for flights operated by the defendant Avior Airlines. According to the plaintiffs’ compliant, the plaintiffs purchased tickets from Miami to Venezuela. The itineraries and receipts for the tickets indicated that the price “included taxes and fees.” However, on the day of their flights, the plaintiffs alleged that the airline forced passengers to pay an additional $80 “Exit Fee” before they were permitted to board their departing flights to Venezuela.

The plaintiffs filed suit against the airline alleging that the undisclosed fee constituted a breach of their contracts with the airline, formed when they purchased their tickets. The plaintiffs sought to represent a national class defined as “all persons that Avior charged an Exit Fee, from five years prior to the filing of the initial complaint through the earlier of: (i) the date, if any, Avior changes its contract to expressly include Exit Fees; and (ii) the date of class certification.”

The putative class action got off to a rough start, however. The district court dismissed the lawsuit finding that the Airline Deregulation Act preempted the breach of contract claims. According to the district court, the Act preempts all claims related to related to prices, routes, and services and the plaintiffs’ claims fell into the purview of the Act because it related to pricing.

The plaintiffs appealed the dismissal to the Eleventh Circuit, which disagreed with the district court on the issue of preemption. After examining the issue of jurisdiction and satisfying itself that it had jurisdiction to hear the appeal, the Court recounted the history of the Act. As the Court explained, Congress passed the Airline Deregulation Act in 1978 to eliminate regulation of air carrier prices. The Act includes a preemption provision, providing that “a State, political subdivision of a State, or political authority of at least 2 States may not enact or enforce a law, regulation, or other provision having the force and effect of law related to a price, route, or service of an air carrier.” Continue reading ›

The Seventh Circuit in a recently issued decision held that an employer cannot invoke an arbitration provision to evade a shareholder class-action lawsuit seeking broad relief under the Employee Retirement Income Security Act (ERISA), a federal law aimed at protecting participants in private employer retirement plans. In its decision, the Court found that claims under ERISA are generally subject to arbitration, but ultimately concluded that the District Court did not err in denying the defendants’ motion to compel arbitration of plaintiff’s class action under section 1132(a)(2) of ERISA due to a class action waiver in the arbitration agreement that would have precluded the plaintiff from asserting certain statutory rights.

The plaintiff, James Smith, worked for Triad Manufacturing, a shelving and fixture company, back in 2015 and 2016. While employed by Triad, he participated in the company’s employee stock ownership program, known as a “defined contribution plan” under ERISA. Triad’s board of directors created the plan for its employees in early December 2015.

According to his lawsuit, after forming the plan, three members of Triad’s board sold all Triad’s stock to the plan at a price of $58.05 per share, totaling more than $106 million. Four days later the board appointed GreatBanc Trust Company as plan trustee. GreatBanc then approved the transaction, seemingly after it had already occurred. Less than two weeks later, Triad’s share price dropped to $1.85, according to the plan’s financial statements. In effect, what had been valued at over $106 million plummeted in two weeks to just under $4 million. The suit alleges that the earliest the plan’s members could sell their shares was the end of 2016 due to vesting requirements, at which time the shares were worth only $1.15. By the end of 2018, the share price had dipped to less than $1 per share. Continue reading ›

The Nazis viewed modern art as “degenerate” and therefore confiscated whatever pieces of art they found to be “degenerate,” but that didn’t stop them from profiting off those pieces of art.

While the Nazi party refused to display artwork it did not approve of in German museums, they saw nothing wrong with selling the artwork to foreign buyers, which is how many pieces of art confiscated by the Nazis came to be displayed in American museums. That puts those museums in a morally uncomfortable position.

While the Nazis claim they “confiscated” works of art from its citizens, the truth is that they stole the artwork and used the proceeds from selling it to fund a fascist regime that killed millions of people.

In general, American museums recognize that artworks “confiscated” by Nazis are stolen, and that the Nazis had no legal right to sell them. As a result, American museums have returned many pieces of stolen artwork to the heirs of their original owners or creators, but the Philadelphia Museum of Art is still hanging on to “Composition with Blue” by Piet Mondrian, which was “confiscated” by the Nazis and sold to an American during WWII.

Mondrian had given the painting to Sophie Küppers, a German art historian and dealer, shortly after he completed it in 1926. The next year, Küppers moved to the Soviet Union, leaving the painting in Hanover at the Provinzialmuseum. After the Nazis came to power, they “confiscated” the painting, whereupon it was given to Karl Buchholz to sell to a foreign buyer.

Buchholz had a business partner, Curt Valentin, who was based in New York, so Buchholz sent the painting to Valentin to be sold in the United States. Valentin sold it to an art collector named Albert E. Gallatin. Continue reading ›

Contact Information